The Mentholatum Company LimitedBranch (foreign co.)
Manufacture of basic pharmaceutical products
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2019-01-31
Registered address
ul. Przy Bażantarni 11/43, 02-783 Warszawa, Poland
Electronic delivery address
AE:PL-24948-92321-CEIDV-23
Financials
Revenue history
Filing timeliness
Financial statements were filed on time, on average 72 days early.
- 202613/07/2026
- 202502/07/2025
- 202418/06/2024
- 202306/06/2023
- 202212/08/2022
- 202108/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Maciej Adam Misztak – Członek (dyrektor) Zarządu
Andrew John Lawlor – Członek (dyrektor) Zarządu
Linda Anne Mccolgan – Członek (dyrektor) Zarządu
Steve Hossenlopp – Członek (dyrektor) Zarządu
Masaya Saito – Członek (dyrektor) Zarządu
Manner of representation
Unless the directors determine otherwise, the quorum necessary for the validity of actions taken consists of three directors.
Beneficial owners
No beneficial owners recorded for the branch The Mentholatum Company Limited.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Medyczne MedicosS.A. | $4,714,965.98 | cmmedicos.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com |
FAQ
The main business activity of The Mentholatum Company Limited focuses on manufacture of basic pharmaceutical products.
The business was registered in the Polish National Court Register (KRS) on January 31, 2019.
The headquarters is located at: ul. Przy Bażantarni 11, 02-783 Warszawa.
The legal form of this entity is a branch of a foreign entrepreneur.
The latest available financial statement covers the period from March 1, 2025 to February 28, 2026.
Last updated: 2026-10-03